Literature DB >> 18210165

[What are the key symptoms of fibromyalgia? Results of a survey of the German Fibromyalgia Association].

W Häuser1, C Zimmer, E Felde, V Köllner.   

Abstract

INTRODUCTION: A new definition of fibromyalgia syndrome (FMS) based on symptoms and without tender points is discussed from a rheumatological viewpoint.
METHODS: The German Fibromyalgia Association (DFV) developed a questionnaire on potential symptoms in FM based on a list of symptoms established by members of the DFV. The questionnaire was sent to all 3,996 members of the DFV.
RESULTS: Of the 753 questionnaires 699 were returned (95% women, most frequent age between 50-60 years) and evaluated. The rank order of the most frequent symptoms (>or=97% of the respondents) was muscle pain with varying locations, low back pain, fatigue, morning stiffness, non-restorative sleep, concentration problems, lack of energy, low productivity and forgetfulness.
CONCLUSION: The key symptoms of FM are chronic widespread pain, non-restorative sleep and subjective disabilities. The frequency of general and extra-musculoskeletal symptoms underlines that FMS is more than just a "pain disorder".

Entities:  

Mesh:

Year:  2008        PMID: 18210165     DOI: 10.1007/s00482-007-0602-z

Source DB:  PubMed          Journal:  Schmerz        ISSN: 0932-433X            Impact factor:   1.107


  23 in total

1.  [Fibromyalgia -- a somatoform (pain) disorder?].

Authors:  W Häuser; K Bernardy; B Arnold
Journal:  Schmerz       Date:  2006-04       Impact factor: 1.107

2.  The relation between tender points and fibromyalgia symptom variables: evidence that fibromyalgia is not a discrete disorder in the clinic.

Authors:  F Wolfe
Journal:  Ann Rheum Dis       Date:  1997-04       Impact factor: 19.103

3.  Fibromyalgia diagnosis: a comparison of clinical, survey, and American College of Rheumatology criteria.

Authors:  Robert S Katz; Frederick Wolfe; Kaleb Michaud
Journal:  Arthritis Rheum       Date:  2006-01

4.  [Comorbidity in patients with chronic low back pain].

Authors:  M Buchner; E Neubauer; A Barie; M Schiltenwolf
Journal:  Schmerz       Date:  2007-06       Impact factor: 1.107

5.  Fibromyalgia syndrome.

Authors:  Philip J Mease; Daniel J Clauw; Lesley M Arnold; Don L Goldenberg; James Witter; David A Williams; Lee S Simon; C Vibeke Strand; Candace Bramson; Susan Martin; Timothy M Wright; Bruce Littman; J F Wernicke; R Michael Gendreau; Leslie J Crofford
Journal:  J Rheumatol       Date:  2005-11       Impact factor: 4.666

Review 6.  [Generalized tendomyopathy. I: Clinical aspects, follow-up and differential diagnosis].

Authors:  W Müller; J Lautenschläger
Journal:  Z Rheumatol       Date:  1990 Jan-Feb       Impact factor: 1.372

7.  Medically unexplained physical symptoms, anxiety, and depression: a meta-analytic review.

Authors:  Peter Henningsen; Thomas Zimmermann; Heribert Sattel
Journal:  Psychosom Med       Date:  2003 Jul-Aug       Impact factor: 4.312

Review 8.  Management of functional somatic syndromes.

Authors:  Peter Henningsen; Stephan Zipfel; Wolfgang Herzog
Journal:  Lancet       Date:  2007-03-17       Impact factor: 79.321

Review 9.  Classification, epidemiology, and natural history of fibromyalgia.

Authors:  K P White; M Harth
Journal:  Curr Pain Headache Rep       Date:  2001-08

10.  An internet survey of 2,596 people with fibromyalgia.

Authors:  Robert M Bennett; Jessie Jones; Dennis C Turk; I Jon Russell; Lynne Matallana
Journal:  BMC Musculoskelet Disord       Date:  2007-03-09       Impact factor: 2.362

View more
  37 in total

1.  [Comorbid depression mediates the association of childhood/adolescent maltreatment and fibromyalgia syndrome. A study with patients from different clinical settings].

Authors:  M Kosseva; S Schild; R Wilhelm-Schwenk; W Biewer; W Häuser
Journal:  Schmerz       Date:  2010-09       Impact factor: 1.107

Review 2.  [Cognitive impairment in patients suffering from fibromyalgia. An underestimated problem].

Authors:  T Schmidt-Wilcke; P Wood; R Lürding
Journal:  Schmerz       Date:  2010-02       Impact factor: 1.107

3.  [Etiology and pathophysiology of fibromyalgia syndrome and chronic widespread pain].

Authors:  C Sommer; W Häuser; K Gerhold; P Joraschky; F Petzke; T Tölle; N Uçeyler; A Winkelmann; K Thieme
Journal:  Schmerz       Date:  2008-06       Impact factor: 1.107

Review 4.  [Fibromyalgia syndrome: A disease of the small nerve fibers?].

Authors:  N Üçeyler; C Sommer
Journal:  Z Rheumatol       Date:  2015-08       Impact factor: 1.372

Review 5.  [Definition, classification, clinical diagnosis and prognosis of fibromyalgia syndrome : Updated guidelines 2017 and overview of systematic review articles].

Authors:  W Eich; K-J Bär; M Bernateck; M Burgmer; C Dexl; F Petzke; C Sommer; A Winkelmann; W Häuser
Journal:  Schmerz       Date:  2017-06       Impact factor: 1.107

Review 6.  Efficacy of hypnosis/guided imagery in fibromyalgia syndrome--a systematic review and meta-analysis of controlled trials.

Authors:  Kathrin Bernardy; Nicole Füber; Petra Klose; Winfried Häuser
Journal:  BMC Musculoskelet Disord       Date:  2011-06-15       Impact factor: 2.362

7.  Classifying Fibromyalgia Syndrome as a Mental Disorder?-An Ambulatory Assessment Study.

Authors:  Kristina Klaus; Susanne Fischer; Johanna M Doerr; Urs M Nater; Ricarda Mewes
Journal:  Int J Behav Med       Date:  2017-04

8.  Validation and psychometric properties of the Spanish version of the Quality of Life Scale (QOLS) in patients with fibromyalgia.

Authors:  Pedro A Latorre-Román; Antonio Martínez-Amat; Emilio Martínez-López; Angel Moral; María A Santos; Fidel Hita-Contreras
Journal:  Rheumatol Int       Date:  2013-10-06       Impact factor: 2.631

9.  The Revised Fibromyalgia Impact Questionnaire (FIQR): validation and psychometric properties.

Authors:  Robert M Bennett; Ronald Friend; Kim D Jones; Rachel Ward; Bobby K Han; Rebecca L Ross
Journal:  Arthritis Res Ther       Date:  2009-08-10       Impact factor: 5.156

10.  Fibromyalgia syndrome: classification, diagnosis, and treatment.

Authors:  Winfried Häuser; Wolfgang Eich; Markus Herrmann; Detlev O Nutzinger; Marcus Schiltenwolf; Peter Henningsen
Journal:  Dtsch Arztebl Int       Date:  2009-06-05       Impact factor: 5.594

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.